The optimum number of oocytes in IVF treatment: An analysis of 2455 cycles in China

Human Reproduction

Volumn 28, Issue 10, 2013, Pages 2728-2734

  Ji, Jingjuan ^a,b   Liu, Yusheng ^b   Tong, Xian Hong ^b   Luo, Lihua ^b   Ma, Jinlong ^a   Chen, Zijiang ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

in vitro fertilization; live birth rate; oocytes number; optimum; ovarian stimulation

Indexed keywords

FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CELL COUNT; CHINA; COHORT ANALYSIS; CRYOPRESERVATION; EMBRYO; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HUMAN; HUMAN CELL; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OOCYTE; OVARY HYPERSTIMULATION; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SPONTANEOUS ABORTION;

IN VITRO FERTILIZATION; LIVE BIRTH RATE; OOCYTES NUMBER; OPTIMUM; OVARIAN STIMULATION;

ABORTION, SPONTANEOUS; ADULT; CHINA; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMANS; OVARIAN HYPERSTIMULATION SYNDROME; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 84885128784     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/det303     Document Type: Article

References (47)

1. Abdalla H, Thum MY. An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve. Hum Reprod 2004; 19:893-898.
2. Alrayyes S, Fakih H, Khan I. Effect of age and cycle responsiveness in patients undergoing intracytoplasmic sperm injection. Fertil Steril 1997;68: 123-127.
3. Baart EB, Martini E, Eijkemans MJ, Van Opstal D, Beckers NG, Verhoeff A, Macklon NS, Fauser BC. Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: A randomized controlled trial. Hum Reprod 2007;22:980-988.
4. Blondin P, Coenen K, Guilbault LA, Sirard MA. Superovulation can reduce the developmental competence of bovine embryos. Theriogenology 1996;46:1191-1203.
5. Brown JB. Pituitary control of ovarian function-concepts derived form gonadotrophin therapy. Aust N Z J Obstet Gynaecol 1978;18:47-55.
6. Cai QF, Wan F, Huang R, Zhang HW. Factors predicting the cumulative outcome of IVF/ICSI treatment: A multivariable analysis of 2450 patients. Hum Reprod 2011;26:2532-2540.
7. Chuang M, Zapantis A, Taylor M, Jindal SK, Neal-Perry GS, Lieman HJ, Polotsky AJ. Prolonged gonadotropin stimulation is associated with decreased ART success. J Assist Reprod Genet 2010;27:711-717.
8. Devroey P, PolyzosNP, Blockeel C. An OHSS-Free Clinic by segmentation of IVF treatment. Hum Reprod. 2011;26:2593-2597.
9. Fábregues F, Penärrubia J, Vidal E, Casals G, Vanrell JA, Balasch J. Oocyte quality in patients with severe ovarian hyperstimulation syndrome: A self-controlled clinical study. Fertil Steril 2004;82:827-833.
10. Fatemi HM, Doody K, Griesinger G, Witjes H, Mannaerts B. High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol. Hum Reprod 2013;28:442-452.
11. Fauser BC. Step-down follicle-stimulating hormone regimens in polcystic ovary syndrome. In: Filicori M, Flamigni C (eds). Ovulation Induction: Basic Science and Clinical Advances. Amsterdam: Elsevier Science, 1994, 153-162.
12. Fauser BC, Devroey P, Macklon NS. Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet 2005;365:1807-1816.
13. Fiedler K, Ezcurra D. Predicting and preventing ovarian hyperstimulation syndrome (OHSS): The need for individualized not standardized treatment. Reprod Biol Endocrinol 2012;10:32.
14. Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB. Blastocyst score affects implantation and pregnancy outcome: Towards a single blastocyst transfer. Fertil Steril 2000;73:1155-1158.
15. Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z, Caspi E. Ovarian hyperstimulation syndrome: An update review. Obstet Gynecol Surv 1989; 44:430-440.
16. Grossman LC, Michalakis KG, Browne H, Payson MD, Segars JH. The pathophysiology of ovarian hyperstimulation syndrome: An unrecognized compartment syndrome. Fertil Steril 2010;94:1392-1398.
17. Hamoda H, Sunkara S, Khalaf Y, Braude P, EI-Toukhy T. Outcome of fresh IVF/ICSI cycles in relation to the number of oocytes collected: A review of 4, 701 treatment cycles. Hum Reprod 2010;25:i47.
18. Hillier SG. Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum Reprod 1994;9:188-191.
19. Inge GB, Brinsden PR, Elder KT. Oocyte number per live birth in IVF: Were Steptoe and Edwards less wasteful?. Hum Reprod 2005;20:588-592.
20. Ingerslev HJ, Højgaard A, Hindkjaer J, Kesmodel U. A randomized study comparing IVF in the unstimulated cycle with IVF following clomiphene citrate. Hum Reprod 2001;16:696-702.
21. Joo BS, Park SH, An BM, Kim KS, Moon SE, Moon HS. Serum estradiol levels during controlled ovarian hyperstimulation influence the pregnancy outcome of in vitro fertilization in a concentration-dependent manner. Fertil Steril 2010;93:442-446.
22. Kok JD, Looman CW, Weima SM, Te Velde ER. A high number of oocytes obtained after ovarian hyperstimulation for in vitro fertilization or intracytoplasmic sperm injection is not associated with decreased pregnancy outcome. Fertil Steril 2006;85:918-924.
23. Krisher RL. The effect of oocyte quality on development. J Anim Sci 2004; 82:E14-E23.
24. Kyrou D, Popovic-Todorovic B, Fatemi HM, Bourgain C, Haentjens P, Van Landuyt L, Devroey P. Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH antagonist?. Hum Reprod 2009;24:2902-2909.
25. Labarta E, Bosch E, Alamá P, Rubio C, Rodrigo L, Pellicer A. Moderate ovarian stimulation does not increase the incidence of human embryo chromosomal abnormalities in in vitro fertilization cycles. J Clin Endocrinol Metab 2012;97:E1987-E1994.
26. Letterie G, Marshall L, Angle M. The relationship of clinical response, oocyte number, and success in oocyte donor cycles. J Assist Reprod Genet 2005; 22:115-117.
27. Macklon NS, Stouffer RL, Giudice LC, Fauser BC. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev 2006; 27:170-207.
28. Martin JR, Mahutte NG, Arici A, Sakkas D. Impact of duration and dose of gonadotrophins on IVF outcomes. Reprod Biomed Online 2006;13:645-650.
29. McAvey B, Zapantis A, Jindal SK, Lieman HJ, Polotsky AJ. Howmany eggs are needed to produce an assisted reproductive technology baby: Is more always better?. Fertil Steril 2011;96:332-335.
30. Melo M, Busso CE, Bellver J, Alama P, Garrido N, Meseguer M, Pellicer A, Remohí J. GnRH agonist versus recombinant HCG in an oocyte donation programme: A randomised, prospective, controlled, assessor-blind study. Reprod Biomed Online 2009;19:486-492.
31. Mitwally MF, Bhakoo HS, Crickard K, Sullivan MW, Batt RE, Yeh J. Estradiol production during controlled ovarian hyperstimulation correlates with treatment outcome in women undergoing in vitro fertilization-embryo transfer. Fertil Steril 2006;86:588-596.
32. Nastri CO, Ferriani RA, Rocha IA, Martins WP. Ovarian hyperstimulation syndrome: Pathophysiology and prevention. J Assist Reprod Genet 2010; 27:121-128.
33. Olivennes F, Hazout A, Lelaidier C, Freitas S, Fanchin R, de Ziegler D, Frydman R. Four indications for embryo transfer at the blastocyst stage. Hum Reprod 1994;9:2367-2373.
34. Penä JE, Chang PL, Chan LK, Zeitoun K, Thornton MH 2nd, Sauer MV. Supraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles. Hum Reprod 2002;17:83-87.
35. Polinder S, Heijnen EM, Macklon NS, Habbema JD, Fauser BJ, Eijkemans MJ. Cost-effectiveness of a mild compared with a standard strategy for IVF: A randomized comparison using cumulative term live birth as the primary endpoint. Hum Reprod 2008;23:316-323.
36. Silber SJ, Nagy Z, Devroey P, Camus M, Van Steirteghem AC. The effect of female age and ovarian reserve on pregnancy rate in male infertility: Treatment of azoospermia with sperm retrieval and intracytoplasmic sperm injection. Hum Reprod 1997;12:2693-2700.
37. Steptoe PC, Edwards RG. Birth after the reimplantation of a human embryo. Lancet 1978;2:366.
38. Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A. Association between the number of eggs and live birth in IVF treatment: An analysis of 400 135 treatment cycles. Hum Reprod 2011;26:1768-1774.
39. Tarlatzis BC, Kolibianakis EM. GnRH agonists vs antagonists. Best Pract Res Clin Obstet Gynaecol 2007;21:57-65.
40. Toner JP. Ageegg quality, FSH levelegg quantity. Fertil Steril 2003; 79:491.
41. Tong XH, Wu LM, Jin RT, Luo LH, Luan HB, Liu YS. Fertilization rates are improved after IVF if the corona radiata is left intact in vitrified-warmed human oocytes. Hum Reprod 2012;27:3208-3214.
42. Valbuena D, Martin J, de Pablo JL, Remohí J, Pellicer A, Simón C. Increasing levels of estradiol are deleterious to embryonic implantation because they directly affect the embryo. Fertil Steril 2001;76:962-968.
43. van der Gaast MH, Eijkemans MJ, van der Net JB, de Boer EJ, BurgerCW, van Leeuwen FE, Fauser BC, Macklon NS. Optimum number of oocytes for a successful first IVF treatment cycle. Reprod Biomed Online 2006; 13:476-480.
44. Verwoerd GR, MathewsT, Brinsden PR. Optimal follicle and oocyte numbers for cryopreservation of all embryos in IVF cycles at risk of OHSS. Reprod Biomed Online 2008;17:312-317.
45. Vlahos NF, Gregoriou O. Prevention and management of ovarian hyperstimulation syndrome. Ann N Y Acad Sci 2006;1092:247-264.
46. Volpes A, Sammartano F, Coffaro F, Mistretta V, Scaglione P, Allegra A. Number of good quality embryos on day 3 is predictive for both pregnancy and implantation rates in in vitro fertilization/intracytoplasmic sperm injection cycles. Fertil Steril 2004;82:1330-1336.
47. Yih MC, Spandorfer SD, Rosenwaks Z. Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories. Fertil Steril 2005;83:24-29.